DCGI Directs Serum Institute to Suspend Any New Recruitment in Phase Second And Third COVID-19 Vaccine Clinical Trials

The Serum Institute has been directed by the Drug Controller General of India or DGCI to suspend the recruitment of volunteers for the second and third rounds of the Oxford-AstraZeneca Corona Vaccine test. That said, volunteers cannot be recruited until further notice.


AstraZeneca vaccination tests have also been suspended in other countries due to serious physical complications caused by a volunteer in England following the vaccination.

DGCI has instructed VG Somani Serum Institute to pay more attention to the safety of volunteers during covid-19 vaccine testing, to submit plans and reports in this regard.

India and England have also been instructed to submit clearances to the Data and Safety Monitoring Boards, after which the DGCI will decide when the next recruitment of volunteers for the immunization test will begin.

Central drug regulator DGCI has already shown cause for serum in various countries for not informing about stopping AstraZeneca vaccine tests. The question has also been raised as to why a volunteer fell ill.

Serum then informed that they are also keeping the test closed for the time being. According to AstraZeneca, one of the volunteers suddenly fell ill unexpectedly, so they stopped taking the vaccine.

Serum Institute of India said “they are keeping an eye on the situation, and they are keeping the test off until Astrageneca starts the test”. In India, they have tested the vaccine for the first time in the human body, and no one has been diagnosed with the disease.

Leave a Comment